These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 6223812
1. In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci. Bauernfeind A, Petermüller C. Eur J Clin Microbiol; 1982 Oct; 1(5):278-81. PubMed ID: 6223812 [Abstract] [Full Text] [Related]
2. Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci. Tuazon CU, Miller H. Antimicrob Agents Chemother; 1984 Apr; 25(4):411-2. PubMed ID: 6233934 [Abstract] [Full Text] [Related]
3. In vitro activity of teichomycin against isolates of gram-positive bacteria. Fietta A, Bersani C, Mangiarotti P, Gialdroni Grassi G. Chemotherapy; 1983 Apr; 29(4):275-82. PubMed ID: 6223793 [Abstract] [Full Text] [Related]
4. In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin. Cooper MA, Jin YF, Ashby JP, Andrews JM, Wise R. J Antimicrob Chemother; 1990 Aug; 26(2):203-7. PubMed ID: 2145256 [Abstract] [Full Text] [Related]
5. In vitro activity of teicoplanin against gram-positive cocci. Allouch P, Pina P, Chaplain C, Delarbre JM, Geffroy F, Grasmick CP, Marcolin M, Morel A, Pangon B, Rio Y, Sédaillan A. Pathol Biol (Paris); 2000 Oct; 48(8):792-5. PubMed ID: 11244609 [Abstract] [Full Text] [Related]
6. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus. Guenthner SH, Wenzel RP. Antimicrob Agents Chemother; 1984 Aug; 26(2):268-9. PubMed ID: 6237606 [Abstract] [Full Text] [Related]
7. In vitro activity of the new glycopeptide decaplanin. Neu HC, Chin NX, Niu WW. Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):458-62. PubMed ID: 1330562 [Abstract] [Full Text] [Related]
8. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci]. Bezian MC, Ribou G, Masquelier B. Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667 [Abstract] [Full Text] [Related]
9. In vitro susceptibility of gram-positive cocci to paldimycin. Pohlod DJ, Saravolatz LD, Somerville MM. Antimicrob Agents Chemother; 1987 Jan; 31(1):104-7. PubMed ID: 3105438 [Abstract] [Full Text] [Related]
10. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)]. Kayaokay Y, Hasçelik G, Gür D, Akalin E. Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050 [Abstract] [Full Text] [Related]
11. Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci. Machka K, Braveny I. Eur J Clin Microbiol; 1987 Feb; 6(1):96-9. PubMed ID: 3032613 [Abstract] [Full Text] [Related]
12. Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015). Pfaller MA, Mendes RE, Sader HS, Castanheira M, Flamm RK. J Glob Antimicrob Resist; 2017 Dec; 11():4-7. PubMed ID: 28735053 [Abstract] [Full Text] [Related]
13. In vitro activity of teichomycin compared with those of other antibiotics. Neu HC, Labthavikul P. Antimicrob Agents Chemother; 1983 Sep; 24(3):425-8. PubMed ID: 6227282 [Abstract] [Full Text] [Related]
14. Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci. Shonekan D, Mildvan D, Handwerger S. Antimicrob Agents Chemother; 1992 Jul; 36(7):1570-2. PubMed ID: 1324649 [Abstract] [Full Text] [Related]
15. Structure-activity relationships in the series of eremomycin carboxamides. Miroshnikova OV, Printsevskaya SS, Olsufyeva EN, Pavlov AY, Nilius A, Hensey-Rudloff D, Preobrazhenskaya MN. J Antibiot (Tokyo); 2000 Mar; 53(3):286-93. PubMed ID: 10819300 [Abstract] [Full Text] [Related]
16. Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci. Cynamon MH, Granato PA. Antimicrob Agents Chemother; 1982 Mar; 21(3):504-5. PubMed ID: 6213192 [Abstract] [Full Text] [Related]
17. Antimicrobial activity of everninomicin against clinical isolates of Enterococcus spp., Staphylococcus spp., and Streptococcus spp. tested by Etest. Terakubo S, Takemura H, Yamamoto H, Ikejima H, Kunishima H, Kanemitsu K, Kaku M, Shimada J. J Infect Chemother; 2001 Dec; 7(4):263-6. PubMed ID: 11810596 [Abstract] [Full Text] [Related]
18. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns. Marchese A, Debbia EA, Bacca D, Balistreri G, Musolino B, Schito GC. Drugs; 1997 Dec; 54 Suppl 6():11-20. PubMed ID: 9474477 [Abstract] [Full Text] [Related]
19. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD. Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446 [Abstract] [Full Text] [Related]
20. In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin. Pohlod DJ, Saravolatz LD, Somerville MM. J Antimicrob Chemother; 1987 Aug; 20(2):197-202. PubMed ID: 2822646 [Abstract] [Full Text] [Related] Page: [Next] [New Search]